BIOMARIN PHARMACEUTICAL INC's ticker is and the CUSIP is 09061GAH4. A total of 63 filers reported holding BIOMARIN PHARMACEUTICAL INC in Q3 2023. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $8,455,066 | -9.3% | 8,704,000 | -8.2% | 0.24% | -4.8% |
| Q2 2023 | $9,323,983 | -9.7% | 9,478,000 | -6.1% | 0.25% | -11.1% |
| Q1 2023 | $10,326,148 | -9.7% | 10,093,000 | -6.0% | 0.28% | -9.1% |
| Q4 2022 | $11,437,353 | -8.5% | 10,733,000 | -14.0% | 0.31% | -13.3% |
| Q3 2022 | $12,494,000 | +17.9% | 12,475,000 | +16.6% | 0.35% | +23.3% |
| Q2 2022 | $10,595,000 | -27.5% | 10,703,000 | -26.4% | 0.29% | -14.6% |
| Q1 2022 | $14,612,000 | +18.9% | 14,548,000 | +24.5% | 0.34% | +34.9% |
| Q4 2021 | $12,292,000 | +10.3% | 11,686,000 | +7.8% | 0.25% | +2.5% |
| Q3 2021 | $11,147,000 | +257.4% | 10,836,000 | +261.2% | 0.24% | +247.1% |
| Q2 2021 | $3,119,000 | +1.7% | 3,000,000 | 0.0% | 0.07% | -2.8% |
| Q1 2021 | $3,067,000 | -4.6% | 3,000,000 | 0.0% | 0.07% | -12.2% |
| Q4 2020 | $3,216,000 | +54.2% | 3,000,000 | +50.0% | 0.08% | +32.3% |
| Q3 2020 | $2,086,000 | -15.2% | 2,000,000 | 0.0% | 0.06% | -20.5% |
| Q2 2020 | $2,460,000 | +18.2% | 2,000,000 | 0.0% | 0.08% | +5.4% |
| Q1 2020 | $2,081,000 | -1.8% | 2,000,000 | 0.0% | 0.07% | +23.3% |
| Q4 2019 | $2,119,000 | +7.7% | 2,000,000 | 0.0% | 0.06% | 0.0% |
| Q3 2019 | $1,968,000 | -5.5% | 2,000,000 | 0.0% | 0.06% | -6.2% |
| Q2 2019 | $2,082,000 | – | 2,000,000 | – | 0.06% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| SHENKMAN CAPITAL MANAGEMENT INC | 30,138,000 | $29,510,000 | 3.72% |
| PFM Health Sciences, LP | 45,910,000 | $46,002,000 | 1.72% |
| Cheyne Capital Management (UK) LLP | 2,320,000 | $2,330,000 | 1.47% |
| ADVENT CAPITAL MANAGEMENT /DE/ | 41,077,000 | $41,277,000 | 0.66% |
| SSI INVESTMENT MANAGEMENT LLC | 9,071,000 | $9,068,000 | 0.50% |
| PALISADE CAPITAL MANAGEMENT, LP | 14,548,000 | $14,612,000 | 0.34% |
| RWC Asset Management LLP | 7,500,000 | $7,552,000 | 0.21% |
| KBC Group NV | 400,000 | $40,316,000 | 0.15% |
| PROSPECTOR PARTNERS LLC | 1,000,000 | $1,000,000 | 0.12% |
| MACKAY SHIELDS LLC | 11,822,000 | $11,816,000 | 0.10% |